MRI Plus New Score Halves Biopsy Rate for Prostate Cancer MRI Plus New Score Halves Biopsy Rate for Prostate Cancer

Using MRI targeting of lesions along with the Stockholm 3 risk score cut the number of biopsies by 52% compared with the systematic approach.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news